Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Antidote Market

Antidote Market Share

Report ID: GMI9616
Published Date: May 2024
Report Format: PDF

Download Free Sample

Antidote Market Share

The antidote industry is highly competitive, marked by several players striving for market dominance. Providers offer comprehensive testing services with improved efficiency and affordability. This includes advancements in reading, materials used, data reporting, sensor design, and customization. Competition is driven by factors such as the quality, reliability, performance, cost, and compliance with regulatory standards. Strategic partnerships with companies and healthcare networks play a crucial role in market positioning.

Antidote Market Companies

Some of the eminent market participants operating in the antidote industry include:

Alvogen
Aurobindo Pharma Limited
Akorn Operating Company LLC
Baxter International, Inc.
Daiichi Sanko Group
Dr. Reddy’s Laboratories Ltd .
Endo International plc
Emergent Biosolutions Inc.
Fresenius SE & Co. KGaA
Hikma Pharmaceuticals PLC
Nichi-Iko Pharmaceutical Co., Ltd.
Novartis AG
Pfizer Inc.
Viatris Inc.
Zydus Lifesciences Ltd.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The antidote market size was valued at USD 2.3 billion in 2023 and is estimated to grow at 8.1% CAGR from 2024 to 2032, driven by the increasing incidence of overdoses.

Chemical antidote industry is estimated to account for USD 1.9 billion by the end of 2032, as they act quickly, which is vital in emergency situations.

U.S. antidote industry size is likely to witness 7.9% CAGR during 2024-2032, owing to the presence of highly developed healthcare infrastructure with a vast network of hospitals, clinics, and medical facilities.

Alvogen , Aurobindo Pharma Limited, Akorn Operating Company LLC, Baxter International, Inc, Daiichi Sanko Group, Dr. Reddy